FIELD: pharmacy. SUBSTANCE: invention relates to the improved oral pharmaceutical medicinal forms of high dosage of an active substance. An active substance is mycophenolatemophetyl, mycophenolic acid or ranolazine. Indicated active substance is in a liquid state obtained by its heating to the point above its melting point followed by cooling to the point below its melting point. In preferable variant the oral pharmaceutical medicinal form is made as a capsule and contains therapeutically effective amount of mycophenolatemophetyl in liquid state obtained by heating to the first temperature above 95 C followed by cooling to the second temperature below 80 C. EFFECT: improved indices of availability of an active substance, decreased daily doses of drug intake by patients. 19 cl, 6 ex
Title |
Year |
Author |
Number |
ORAL SUSPENSION CONTAINING HIGH DOSE OF MOFETIL MYCOPHENOLATE |
1994 |
- Debora M. Lidgejt
- Li-Khua Vang-Kessler
- Bindu Dzhoshi
- Saje Dzh. Khedzh
- Leo Gu
|
RU2150942C1 |
RANOLAZINE PREPARATIONS WITH PROLONGED EFFECT |
1999 |
- Vol'Ff Ehndrju A.
- Behjker Fiona
- Lehngridzh Dzhon
|
RU2214233C2 |
DERIVATIVES OF 10,11-METHANEDIBENZOSUBERANE, CHEMOSENSIBILIZING COMPOSITION, METHOD RESISTANCE TO ANTITUMOR DRUG OVERCOMING AND METHOD OF TREATMENT OF PATIENTS WITH TUMOR DISEASES |
1994 |
- Jurg Roland Pfister
- Doris Linn Slejt
|
RU2167154C2 |
ANHYDROUS CRYSTALLINE MOFETYL MICOPHENOLATE, INTRAVENOUS COMPOSITION BASED THEREOF, AND FORMULATION SUITABLE FOR PREPARING INTRAVENOUS AQUEOUS COMPOSITION |
1994 |
- Rozher Cherng Fu
- De-Mej Leung
- Dzheffri S.Flejtman
- Mikele S.Rizzolio
|
RU2132849C1 |
DIMETANSULPHONATE N-HYDROXY-4{5-[4-(5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL)PHENOXY]PENTOXY}BENZAMIDINE |
2005 |
- Riu Dzej Mehn
- Li Dzin Soo
- Shin Dong Khiuk
- Seong Seung Kioo
- Cho Soon Ki
- Dzeon Chan Seok
- Dzin Jang Goo
- Li Ki Jang
- Dzung Se Khiun
- Cho Eun Khee
- Akhn Seok Khoon
|
RU2361867C2 |
PHARMACEUTICAL FORMULATIONS OF HIF HYDROXYLASE INHIBITORS |
2014 |
- Konka Devid
- Flippin Li Allen
- Lej Skott Devid
- Vitshi Klaudiya
- Rajt Li Robert
|
RU2681304C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
|
RU2780377C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2781638C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yungo
- Van, Gaosen
- Gao, Khuejshen
|
RU2772875C1 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND AN SGLT-2 INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2770043C1 |